Search

Using Multiple Technologies to Maximize Quality of Vision

I. Paul Singh, MD

Show Description +

In the age of interventional glaucoma, surgeons often must utilize multiple technologies to help reduce the glaucoma medication burden and maximize quality of vision. In this case, I. Paul Singh, MD, uses the Hydrus Microstent (Alcon), iDose TR (Glaukos), an enVista Aspire Toric IOL (Bausch + Lomb), and Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix).

Financial Disclosures: Consultant (Alcon, Bausch + Lomb, Glaukos)

Posted: 10/27/2025

Keywords:

Hydrus Microstent (Alcon)

•

iDose TR

Up Next

Management of Dislocated Posterior Chamber IOL

Management of Dislocated Posterior Chamber IOL

Altan A. Ozcan, MD

Posterior Lamellar Keratoplasty and Dislocated IOL

Posterior Lamellar Keratoplasty and Dislocated IOL

Ozana Moraru, MD

Scleral Fixation of Dislocated IOL Complex

Scleral Fixation of Dislocated IOL Complex

Majid Moshirfar, MD

PXF Dislocated IOL, IOL Exchange with Gortex Sutured IOL

PXF Dislocated IOL, IOL Exchange with Gortex Sutured IOL

Michael Patterson, DO

Refixation of a Dislocated Gortex Sutured Akreos IOL

Refixation of a Dislocated Gortex Sutured Akreos IOL

Jason N. Crosson, MD, Michael A. Albert MD

Dislocated IOL to Glued IOL

Dislocated IOL to Glued IOL

Michael Patterson, DO

Bubble Bubble Toil and Trouble

Bubble Bubble Toil and Trouble

Jason Jones, MD

Phacoemulsification Hard Cataract With Lens Coloboma

Phacoemulsification Hard Cataract With Lens Coloboma

Maneesh Bapaye, MD

Phaco Debulk Chop for Dense Cataracts

Phaco Debulk Chop for Dense Cataracts

Iqbal "Ike" K. Ahmed, MD, FRCSC

My Technique for Modern ECCE

My Technique for Modern ECCE

Ashraf Armia, MD

Using Multiple Technologies to Maximize Quality of Vision

I. Paul Singh, MD

In the age of interventional glaucoma, surgeons often must utilize multiple technologies to help reduce the glaucoma medication burden and maximize quality of vision. In this case, I. Paul Singh, MD, uses the Hydrus Microstent (Alcon), iDose TR (Glaukos), an enVista Aspire Toric IOL (Bausch + Lomb), and Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix).

Financial Disclosures: Consultant (Alcon, Bausch + Lomb, Glaukos)

Posted: 10/27/2025

Keywords:

Hydrus Microstent (Alcon)

•

iDose TR

Please log in to leave a comment.

More in Cataract

Innovations in Drug Delivery: A Drug-Delivering IOL

Innovations in Drug Delivery: A Drug-Delivering IOL

I. Paul Singh, MD; and Douglas McGraw, DO

UNITYtime Podcast Episode 2: Exploring the UNITY® VCS/CS System

UNITYtime Podcast Episode 2: Exploring the UNITY® VCS/CS System

Lorraine M. Provencher, MD; and Arjan Hura, MD

Phacoemulsification With Real-Time Remote Collaboration

Phacoemulsification With Real-Time Remote Collaboration

Ernesto Calvo, MD; Salomon Abouganem, MD; and Eric Rosenberg, DO

Case-Based Confidence With LenSx® OnAxis

Case-Based Confidence With LenSx® OnAxis

Zarmeena Vendal, MD; Scott LaBorwit, MD; and Heather Weissman, MD